DNA and RNA aptamers are high-affinity, nucleotide-based binding molecules which, as an alternative to antibodies, are already being widely used in analytics, diagnostics and therapeutics. The generation of new aptamers and their industrial implementation opens up new potentials for a wide ... more
Dr. Marcus Menger
Fraunhofer-Institut für Zelltherapie und Immunologie, Institutsteil Bioanalytik und Bioprozesse (IZI-BB), Potsdam
Marcus Menger, born in 1969, graduated with a diploma in chemistry from the Georg-August-University in Göttingen. After completing his doctorate at the Department of Biochemical Kinetics at the Max Planck Institute for Biophysical Chemistry in Göttingen, he spent 15 years in the biotechnology industry. Until 2014 he headed the aptamer department of the biotechnology company RiNA GmbH in Berlin. In 2015 he moved to the Fraunhofer Institute for Cell Therapy and Immunology, Branch Bioanalytics and Bioprocesses (IZI-BB) in Potsdam, where he established the working group "Functional Nucleic Acids – Aptamers".
Marcus Menger has been a director of the Executive Committee of the International Society on Aptamers (INSOAP) since 2014.
Ever since 2002, the research interests of Marcus Menger have been aptamer technology and its applications. The focus of his work is the generation and synthesis of aptamers and their transfer to industrial applications.
Carpe diem and keep curious!